Clinical Studies

See below for the Division of Infectious Diseases current clinical studies. 

Transplant Infectious Disease

Efficacy and Safety of Maribavir in Transplant Recipients with Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment
The purpose of this study is to assess the efficacy and safety of maribavir treatment compared to investigator-assigned treatment in transplant recipients with cytomegalovirus (CMV) Infections that are refractory or resistant to treatment with ganciclovir, valganciclovir, foscarnet, or cidofovir.

Principal Investigator: Daniel Kaul, MD

Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus
The primary objective of this study is to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients.

Principal Investigator: Daniel Kaul, MD

Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus (CMV) Disease in Kidney Transplant Recipients
The primary objective of this study is to evaluate the efficacy of letermovir (LET) versus valganciclovir (VGCV) in preventing CMV disease in adult kidney transplant recipients.

Principal Investigator: Kevin Gregg, MD